publication date: Dec. 19, 2010

In this issue: 

SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

National Cancer Policy Board calls for public-private partnership for R&D in pediatric cancer drugs.

Paulette Gray named director of NCI Division of Extramural Activities.

Download (PDF 337KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.